Copeptin in relation to New York heart association class in heart transplant recipients and kidney transplant recipients

Transplantation Proceedings

Volumn 42, Issue 10, 2010, Pages 4259-4262

  Malyszko, J ^b   Przybylowski, P ^a   Koc Zorawska, E ^b   Iaina Levin, N ^c   Sadowski, J ^a   Mysliwiec, M ^b   Malyszko, J S ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; COPEPTIN; CREATININE; CYSTATIN C; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE; LIPID; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUROHYPOPHYSIS HORMONE; PREDNISONE; UNCLASSIFIED DRUG; UREA; VASOPRESSIN;

ADULT; AGED; BLOOD CELL COUNT; CARDIAC GRAFT REJECTION; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HEART EJECTION FRACTION; HEART FUNCTION; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; GLOMERULAR FILTRATION RATE; GLYCOPEPTIDES; HEART TRANSPLANTATION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SOCIETIES, MEDICAL;

EID: 78650458478     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.031     Document Type: Conference Paper

References (27)

1. I. Gotsman, S. Rubonivich, and T. Azaz-Livshits Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome Isr Med Assoc J 10 2008 214
2. A. Al-Ahmad, W.M. Rand, and G. Manjunath Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction J Am Coll Cardiol 38 2001 955
3. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1
4. B.R. Hemmelgarn, B.J. Manns, and A. Lloyd Relation between kidney function, proteinuria, and adverse outcomes JAMA 303 2010 423
5. A.O. Ojo, P.J. Held, and F.K. Port Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931
6. B.W. Miller Chronic kidney disease in solid-organ transplantation Adv Chronic Kidney Dis 13 2006 29
7. C.M. Costa de Oliveira, M.U. Mota, and R.S. Mota Prevalence and staging of chronic kidney disease in renal transplant recipients Clin Transplant 23 2009 628
8. J. Malyszko, J.S. Malyszko, and M. Mysliwiec Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients Clin Transplant 23 2009 681
9. K.C. Abbott, C.M. Yuan, and A.J. Taylor Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression J Am Soc Nephrol 14 2003 2358
10. K. Itoi, Y.Q. Jiang, and Y. Iwasaki Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus J Neuroendocrinol 16 2004 348
11. N.G. Morgenthaler Copeptin: a biomarker of cardiovascular and renal function Congest Heart Fail 16 suppl 1 2010 S37
12. L.A. Stevens, C.H. Schmid, and Y.L. Zhang Development and validation of GFR-estimating equations using diabetes, transplant and weight Nephrol Dial Transplant 25 2010 449
13. N.G. Morgenthaler, J. Struck, and C. Alonso Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin Clin Chem 52 2006 112
14. A. Gegenhuber, J. Struck, and B. Dieplinger Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure J Card Fail 13 2007 42
15. B. Stoiser, D. Mortl, and M. Hulsmann Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure Eur J Clin Invest 36 2006 771
16. D.O. Taylor, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report2008 J Heart Lung Transplant 27 2008 943
17. A.S. Go, G.M. Chertow, and D. Fan Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296
18. S.G. Wannamethee, A.G. Shaper, and I.J. Perry Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke Stroke 28 1997 557
19. N.S. Anavekar, J.J. McMurray, and E.J. Velazquez Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285
20. J. Malyszko, H. Bachorzewska-Gajewska, and J. Malyszko Prevalence of chronic kidney disease (CKD) and anemia in patients with coronary artery disease with normal serum creatinine, undergoing percutaneous coronary interventions (PCI), in relation to New York Heart Association (NYHA) class Isr Med Assoc J 12 2010 7
21. E. Zamora, J. Lupn, and A. Urrutia Estimated creatinine clearance: a determinant prognostic factor in heart failure Med Clin (Barc) 131 2008 47
22. S.Q. Khan, O.S. Dhillon, and R.J. O'Brien C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study Circulation 115 2007 2103
23. S.S. Bhandari, I. Loke, and J.E. Davies Gender and renal function influence plasma levels of copeptin in healthy individuals Clin Sci (Lond) 116 2009 257
24. E. Meijer, S.J. Bakker, and N. Halbesma Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort Kidney Int 77 2010 29
25. H. Okada, H. Suzuki, and Y. Kanno Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats Clin Sci (Lond) 86 1994 399
26. A.W. Cowley Jr, M.M. Skelton, and T.M. Kurth Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial pressure Am J Physiol 275 1998 R1420
27. E. Meijer, S.J. Bakker, and P.E. de Jong Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients Transplantation 88 2009 561